| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $2K | — | — |
| SG&A Expense | $798K | — | +55.4% |
| Operating Income | -$805K | — | -53.9% |
| Interest Expense | $995 | — | -69.3% |
| Pre-tax Income | -$711K | — | -74.1% |
| Net Income | -$711K | — | -74.1% |
| EPS (Basic) | -$0.06 | — | -50.0% |
| EPS (Diluted) | -$0.06 | — | -50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $79K | -85.2% | -92.9% |
| Accounts Receivable | $254K | +2.0% | +644.1% |
| Current Assets | $437K | -55.8% | -80.5% |
| Total Assets | $37.5M | -1.6% | +297.7% |
| Current Liabilities | $4.6M | +1.2% | +717.5% |
| Total Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$364K | — | -83.9% |
| Financing Cash Flow | -$87K | — | +3.6% |
| $6.2M |
| -0.0% |
| +162.1% |
| Stockholders' Equity | $31.3M | -1.9% | +343.1% |